CVS Health Corporation (CVS) Rating Reiterated by Deutsche Bank AG, Report finds

CVS Health Corporation (CVS) Rating Reiterated by Deutsche Bank AG, Report finds

CVS Health Corporation (NYSE:CVS)‘s stock had its “hold” rating reaffirmed by equities research analysts at Deutsche Bank AG in a report released on Wednesday. They presently have a $88.00 target price on the pharmacy operator’s stock. Deutsche Bank AG’s price objective points to a potential upside of 14.24% from the company’s previous close.

A number of other equities analysts also recently issued reports on the company. Vetr raised CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $98.36 price target for the company in a report on Monday, October 24th. Guggenheim reaffirmed a “buy” rating and issued a $90.00 price target (down from $115.00) on shares of CVS Health Corporation in a report on Tuesday, November 8th. Mizuho upped their price target on CVS Health Corporation from $90.00 to $111.00 and gave the company a “buy” rating in a report on Wednesday, November 9th. Leerink Swann reaffirmed a “buy” rating and issued a $105.00 price target on shares of CVS Health Corporation in a report on Wednesday, November 9th. Finally, Barclays PLC reaffirmed a “buy” rating and issued a $85.00 price target on shares of CVS Health Corporation in a report on Wednesday, November 9th. Eight analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $97.99.

CVS Health Corporation (NYSE:CVS) traded up 0.88% during trading on Wednesday, reaching $77.03. 6,788,496 shares of the company’s stock were exchanged. CVS Health Corporation has a 52 week low of $69.30 and a 52 week high of $106.67. The stock has a 50-day moving average of $79.89 and a 200-day moving average of $85.31. The stock has a market capitalization of $82.15 billion, a PE ratio of 16.51 and a beta of 0.85.

The company also recently announced a quarterly dividend, which was paid on Thursday, February 2nd. Shareholders of record on Tuesday, January 24th were issued a $0.50 dividend. This is a positive change from CVS Health Corporation’s previous quarterly dividend of $0.43. The ex-dividend date was Friday, January 20th. This represents a $2.00 annualized dividend and a yield of 2.60%. CVS Health Corporation’s dividend payout ratio is 42.83%.

Hedge funds have recently bought and sold shares of the stock. Beacon Capital Management raised its stake in CVS Health Corporation by 1.7% in the fourth quarter. Beacon Capital Management now owns 366 shares of the pharmacy operator’s stock worth $36,000 after buying an additional 6 shares during the last quarter. Acrospire Investment Management LLC raised its stake in CVS Health Corporation by 542.2% in the second quarter. Acrospire Investment Management LLC now owns 1,066 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 900 shares during the last quarter. MU Investments Co. Ltd. raised its stake in CVS Health Corporation by 62.0% in the second quarter. MU Investments Co. Ltd. now owns 1,150 shares of the pharmacy operator’s stock worth $109,000 after buying an additional 440 shares during the last quarter. D Orazio & Associates Inc. raised its stake in CVS Health Corporation by 9.4% in the second quarter. D Orazio & Associates Inc. now owns 1,160 shares of the pharmacy operator’s stock worth $111,000 after buying an additional 100 shares during the last quarter. Finally, Springbok Capital Management LLC raised its stake in CVS Health Corporation by 190.5% in the first quarter. Springbok Capital Management LLC now owns 1,130 shares of the pharmacy operator’s stock worth $117,000 after buying an additional 741 shares during the last quarter. 81.39% of the stock is currently owned by institutional investors.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

Related posts

Leave a Comment

CVS Health Corporation (CVS) Rating Reiterated by Deutsche Bank AG

CVS Health Corporation (CVS) Rating Reiterated by Deutsche Bank AG

CVS Health Corporation (NYSE:CVS)‘s stock had its “hold” rating reaffirmed by equities research analysts at Deutsche Bank AG in a report released on Wednesday. They presently have a $88.00 target price on the pharmacy operator’s stock. Deutsche Bank AG’s price objective points to a potential upside of 14.24% from the company’s previous close.

A number of other equities analysts also recently issued reports on the company. Vetr raised CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $98.36 price target for the company in a report on Monday, October 24th. Guggenheim reaffirmed a “buy” rating and issued a $90.00 price target (down from $115.00) on shares of CVS Health Corporation in a report on Tuesday, November 8th. Mizuho upped their price target on CVS Health Corporation from $90.00 to $111.00 and gave the company a “buy” rating in a report on Wednesday, November 9th. Leerink Swann reaffirmed a “buy” rating and issued a $105.00 price target on shares of CVS Health Corporation in a report on Wednesday, November 9th. Finally, Barclays PLC reaffirmed a “buy” rating and issued a $85.00 price target on shares of CVS Health Corporation in a report on Wednesday, November 9th. Eight analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $97.99.

CVS Health Corporation (NYSE:CVS) traded up 0.88% during trading on Wednesday, reaching $77.03. 6,788,496 shares of the company’s stock were exchanged. CVS Health Corporation has a 52 week low of $69.30 and a 52 week high of $106.67. The stock has a 50-day moving average of $79.89 and a 200-day moving average of $85.31. The stock has a market capitalization of $82.15 billion, a PE ratio of 16.51 and a beta of 0.85.

The company also recently announced a quarterly dividend, which was paid on Thursday, February 2nd. Shareholders of record on Tuesday, January 24th were issued a $0.50 dividend. This is a positive change from CVS Health Corporation’s previous quarterly dividend of $0.43. The ex-dividend date was Friday, January 20th. This represents a $2.00 annualized dividend and a yield of 2.60%. CVS Health Corporation’s dividend payout ratio is 42.83%.

Hedge funds have recently bought and sold shares of the stock. Beacon Capital Management raised its stake in CVS Health Corporation by 1.7% in the fourth quarter. Beacon Capital Management now owns 366 shares of the pharmacy operator’s stock worth $36,000 after buying an additional 6 shares during the last quarter. Acrospire Investment Management LLC raised its stake in CVS Health Corporation by 542.2% in the second quarter. Acrospire Investment Management LLC now owns 1,066 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 900 shares during the last quarter. MU Investments Co. Ltd. raised its stake in CVS Health Corporation by 62.0% in the second quarter. MU Investments Co. Ltd. now owns 1,150 shares of the pharmacy operator’s stock worth $109,000 after buying an additional 440 shares during the last quarter. D Orazio & Associates Inc. raised its stake in CVS Health Corporation by 9.4% in the second quarter. D Orazio & Associates Inc. now owns 1,160 shares of the pharmacy operator’s stock worth $111,000 after buying an additional 100 shares during the last quarter. Finally, Springbok Capital Management LLC raised its stake in CVS Health Corporation by 190.5% in the first quarter. Springbok Capital Management LLC now owns 1,130 shares of the pharmacy operator’s stock worth $117,000 after buying an additional 741 shares during the last quarter. 81.39% of the stock is currently owned by institutional investors.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

Related posts

Leave a Comment